These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 39205268
1. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes. Law N, Logan C, Taplitz R. Viruses; 2024 Aug 14; 16(8):. PubMed ID: 39205268 [Abstract] [Full Text] [Related]
2. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment. Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T. Transpl Infect Dis; 2016 Feb 14; 18(1):44-54. PubMed ID: 26574232 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation. Lindsay J, Yong MK, Greenwood M, Kong DCM, Chen SCA, Rawlinson W, Slavin M. Rev Med Virol; 2020 Jul 14; 30(4):e2108. PubMed ID: 32301566 [Abstract] [Full Text] [Related]
4. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Styczynski J, Einsele H, Gil L, Ljungman P. Transpl Infect Dis; 2009 Oct 14; 11(5):383-92. PubMed ID: 19558376 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation. Liu QF, Fan ZP, Luo XD, Sun J, Zhang Y, Ding YQ. Transpl Infect Dis; 2010 Aug 01; 12(4):284-91. PubMed ID: 20345506 [Abstract] [Full Text] [Related]
12. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention? Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF. Pediatr Blood Cancer; 2006 Aug 01; 47(2):200-5. PubMed ID: 16206207 [Abstract] [Full Text] [Related]
14. [The diagnostic value of whole blood Epstein-Barr virus DNA load in lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation]. Niu YY, Dong YJ, Yin Y, Xu WL, Liang ZY, Wang Q, Li Y, Liu W, Ou JP, Ren HY. Zhonghua Xue Ye Xue Za Zhi; 2021 Nov 14; 42(11):904-910. PubMed ID: 35045651 [Abstract] [Full Text] [Related]
17. Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus. Han SB, Bae EY, Lee JW, Jang PS, Lee DG, Chung NG, Jeong DC, Cho B, Lee SJ, Kang JH, Kim HK. Int J Hematol; 2014 Aug 14; 100(2):188-99. PubMed ID: 24981711 [Abstract] [Full Text] [Related]
20. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, Beneyto I, Espí J, Gómez-Codina J, Iacoboni G, Jarque I, López-Andújar R, Mayordomo-Aranda E, Montalar J, Pastor A, Pastor M, Piñana JL, Rojas-Ferrer N, Sánchez-Lázaro I, Sandoval J, Sanz G, Sanz MÁ, Solé A, Sanz J. Leuk Lymphoma; 2019 Jan 14; 60(1):142-150. PubMed ID: 29966464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]